To Boldly Remember Where We Have Already Been

I-36: Preimplantation Genetic Diagnosis - Where Have We Been and Where Are We Going

Preimplantation genetic diagnosis (PGD) is now considered routine in IVF laboratories with micromanipulation capability and access to genetic diagnostic services. The past two decades have witnessed a dramatic increase in the use of PGD, the number of cycles performed, and the indications for which PGD has been used. This increase has been mirrored by a slow, but steady, increase in the range o...

Where we have been, where we are going.

To BOLDly go where positron emission tomography has been before.

Atherosclerotic disease remains concealed for many years and becomes clinically overt only when the growth of atherosclerotic plaques and the adverse remodeling of the arterial wall reach a critical stage that results in impairment of blood flow, ischemia, and angina. Large epicardial arteries have a diameter ranging from a few millimeters to 500 m and are visible at coronary angiography. Prear...

Foreclosure P Roceedings : Where We Have Been and Where We Need to Go

Exercise and Duchenne muscular dystrophy: where we have been and where we need to go.

EXERCISE AND DUCHENNE MUSCULAR DYSTROPHY: WHERE WE HAVE BEEN AND WHERE WE NEED TO GO CHAD D. MARKERT, PhD, LAURA E. CASE, DPT, PCS, GREGORY T. CARTER, MD, MS, PATRICIA A. FURLONG, RN, BSN, MS, and ROBERT W. GRANGE, PhD Wake Forest Institute for Regenerative Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA Division of Physical Therapy, Department of Community and Family...